losartan has been researched along with quinapril in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (23.08) | 18.2507 |
| 2000's | 22 (56.41) | 29.6817 |
| 2010's | 8 (20.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boxer, M | 1 |
| Bizollon, CA; Gharib, C; Lantelme, P; Lo, M; Mullins, JJ; Sassard, J | 1 |
| Böhm, M; Flesch, M; Paul, M; Pinto, YM; Schnabel, P; Teisman, AC; van Gilst, WH; Zolk, O | 1 |
| Anders, HJ; Ertl, G; Gaudron, P; Hu, K; Nahrendorf, M; Turschner, O; Weidemann, F | 1 |
| Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH | 1 |
| Banga, JD; Erkelens, WD; Hijmering, M; Rabelink, TJ; Stroes, ES; Wilmink, HW | 1 |
| Daihara, M; Kawahara, K; Nakagawa, H; Nozue, T; Tamakawa, H | 1 |
| Agirbasli, M; Brown, NJ; Vaughan, DE | 1 |
| Bastien, NR; Juneau, AV; Lambert, C; Ouellette, J | 1 |
| Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
| Kawai, H; Liang, CS; Stevens, SY | 1 |
| Bavry, AA; Li, D; Mehta, JL; Phillips, MI; Zander, DS | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Glantz, SA; Parmley, WW; Pulukurthy, S; Sudhir, K; Sun, YP; Zhu, BQ | 1 |
| Boon, NA; Johnston, NR; Labinjoh, C; Newby, DE; Pellegrini, MP; Webb, DJ | 1 |
| Leenen, FH; White, R; Yuan, B | 1 |
| Doi, O; Ishikawa, J; Nawada, R; Obayashi, K; Sakata, K; Tamekiyo, H; Yoshida, H | 1 |
| Böhm, M; Müller, C; Nickenig, G; Stäblein, A; Wassmann, S; Wyen, C | 1 |
| Gerhardt, U; Hillebrand, U; Hohage, H; Kobelt, V; Matzkies, F; Sindermann, J; Suwelack, B; vOphoven, M | 1 |
| Fujiwara, N; Kato, T; Konta, Y; Metoki, N; Okuguchi, T; Okumura, K; Osanai, T | 1 |
| Kawecka-Jaszcz, K; Klocek, M; Rajzer, M | 1 |
| Alonso, C; Catalán, MP; Egido, J; Gallego-Delgado, J; Gómez-Garre, D; Largo, R; Ortiz, A; Plaza, JJ; Soto, K; Tejera, N | 1 |
| Barat, A; Bosch, RJ; Esbrit, P; Gazapo, R; González, L; Izquierdo, A; Ortega, A; Rámila, D | 1 |
| Fukui, M; Hasegawa, T; Iwasaka, T; Kijima, Y; Kishimoto, N; Kosaki, A; Matsubara, H; Mori, Y; Nose, A; Uchiyama-Tanaka, Y; Yamahara, H | 1 |
| Barderas, MG; Duran, MC; Egido, J; Gallego-Delgado, J; Lazaro, A; Osende, JI; Vivanco, F | 1 |
| Egido, J; Gállego-Delgado, J; Lázaro, A; Osende, JI; Vivanco, F | 1 |
| Chua, CL; Goh, SK; Heng, BL; Koh, AF; Lim, SC; Subramaniam, T; Sum, CF | 1 |
| Gregg, AM; Kloner, RA; Neutel, J; Roth, EM; Schwartz, B; Shi, H; Thakker, KM; Weinberger, MH; Weiss, R | 1 |
| Koller, A; Lotz, G; Racz, A; Veresh, Z | 1 |
| Brady, HR; Connolly, SB; Doran, P; Egido, J; Gallego-Delgado, J; Kieran, NE; Lázaro, A; Osende, J; Sadlier, D; Sugrue, DD | 1 |
| Kawecka-Jaszcz, K; Rajzer, M; Undas, A; Wojciechowska, W | 1 |
| Lim, SC; Liu, JJ; Subramaniam, T; Sum, CF | 1 |
| Alexaki, E; Bramos, D; Georgiopoulos, G; Kaladaridou, A; Kolyviras, A; Koroboki, E; Manios, E; Stamatelopoulos, K; Stellos, K; Toumanidis, S; Zakopoulos, N | 1 |
2 review(s) available for losartan and quinapril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 trial(s) available for losartan and quinapril
| Article | Year |
|---|---|
Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Postprandial Period; Quinapril; Tetrahydroisoquinolines; Vasodilation | 1999 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Brachial Artery; Bradykinin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Endothelium, Vascular; Fibrinolysis; Forearm; Humans; Infusions, Intravenous; Isoquinolines; Losartan; Male; Nitroprusside; Plethysmography, Impedance; Quinapril; Substance P; Tetrahydroisoquinolines; Tissue Plasminogen Activator; Vasodilator Agents | 2001 |
Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Heart; Hemodynamics; Humans; Hypertension; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Radionuclide Imaging; Radiopharmaceuticals; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrahydroisoquinolines; Treatment Outcome | 2002 |
Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Female; Humans; Hypertension; Isoquinolines; Losartan; Male; Middle Aged; Prospective Studies; Quinapril; Stroke; Tetrahydroisoquinolines; Treatment Outcome | 2002 |
Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Collagen; Compliance; Echocardiography; Elasticity; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pulsatile Flow; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines | 2003 |
Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Carotid Artery Diseases; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Treatment Outcome; Tunica Intima; Tunica Media | 2005 |
Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Losartan; Male; Middle Aged; Quinapril; Singapore; Tetrahydroisoquinolines | 2007 |
Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2008 |
Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication.
Topics: Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Coagulation; Female; Fibrin; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2012 |
Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucuronidase; Humans; Klotho Proteins; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2014 |
26 other study(ies) available for losartan and quinapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Accupril- and Cozaar-induced angioedema in the same patient.
Topics: Angioedema; Antihypertensive Agents; Biphenyl Compounds; Humans; Imidazoles; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Tetrazoles | 1996 |
Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Isoquinolines; Losartan; Male; Natriuresis; Quinapril; Rats; Tetrahydroisoquinolines; Tetrazoles | 1996 |
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Topics: Adenylyl Cyclases; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; GTP-Binding Proteins; Hydralazine; Isoquinolines; Losartan; Myocardium; Neuropeptides; Organ Size; Quinapril; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Vasodilator Agents | 1998 |
Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Isoquinolines; Losartan; Male; Myocardial Infarction; Organ Size; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1998 |
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines | 1998 |
Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Chemical Analysis; Blood Pressure; Bradykinin; Drug Resistance; Drug Synergism; Glucose; Glucose Clamp Technique; Hypertension; Insulin; Isoquinolines; Losartan; Male; Quinapril; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines | 1999 |
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Data Interpretation, Statistical; Diet, Sodium-Restricted; Female; Fibrinolysis; Heart Rate; Humans; Isoquinolines; Losartan; Male; Plasminogen Activator Inhibitor 1; Quinapril; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 1999 |
Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Topics: Alanine Transaminase; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Creatinine; Cricetinae; Evaluation Studies as Topic; Isoquinolines; Losartan; Male; Mesocricetus; Myocardium; Potassium; Quinapril; Sodium; Tetrahydroisoquinolines | 1999 |
Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Fluorescent Antibody Technique; Heart; Heart Failure; Hemodynamics; Isoquinolines; Losartan; Neurons; Norepinephrine; Pacemaker, Artificial; Presynaptic Terminals; Quinapril; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase; Ventricular Function, Left | 2000 |
Inhibition of arterial thrombogenesis by quinapril but not losartan.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Isoquinolines; Losartan; Male; Platelet Aggregation; Quinapril; Rats; Rats, Sprague-Dawley; Superoxides; Tetrahydroisoquinolines; Thrombosis | 2000 |
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Captopril; Cholesterol; Disease Models, Animal; Isoquinolines; Kinins; Losartan; Male; Nitric Oxide; Quinapril; Rabbits; Receptors, Angiotensin; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2001 |
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Topics: Adrenergic beta-Agonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen; Coronary Circulation; Heart Rate; Isoproterenol; Isoquinolines; Losartan; Male; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines | 2001 |
Acute effects of ACE inhibition on coronary endothelial dysfunction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Microcirculation; Middle Aged; Quinapril; Receptor, Angiotensin, Type 1; Tetrahydroisoquinolines; Time Factors; Vasodilation; Vasomotor System | 2000 |
Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine A-treated rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclosporine; Hemodynamics; Immunosuppressive Agents; Isoquinolines; Laser-Doppler Flowmetry; Losartan; Male; Microcirculation; Quinapril; Rats; Rats, Wistar; Renal Circulation; Tetrahydroisoquinolines | 2002 |
Tight blood pressure control decreases apoptosis during renal damage.
Topics: Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cell Division; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Immunohistochemistry; Losartan; Male; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Tetrahydroisoquinolines | 2004 |
Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Enalapril; Folic Acid; Gentamicins; Kidney; Kidney Tubules; Losartan; Male; Parathyroid Hormone-Related Protein; Quinapril; Rats; Rats, Wistar; Receptor, Parathyroid Hormone, Type 1; Renin-Angiotensin System; Tetrahydroisoquinolines | 2005 |
Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.
Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Blood Pressure; Doxazosin; Electrophoresis, Gel, Two-Dimensional; Hypertrophy, Left Ventricular; Losartan; Molecular Sequence Data; Myocardium; Proteomics; Quinapril; Rats; Rats, Inbred WKY; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrahydroisoquinolines | 2006 |
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach.
Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Heart; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Myocardium; Proteomics; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2007 |
ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin II-NAD(P)H oxidase pathway.
Topics: Acetophenones; Angiotensin II; Animals; Arginine; Arterioles; Enzyme Inhibitors; Losartan; Male; Muscle, Skeletal; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Quinapril; Rats; Rats, Wistar; Signal Transduction; Superoxides; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2008 |
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies.
Topics: Animals; Antihypertensive Agents; Doxazosin; Drug Therapy, Combination; Gene Expression; Gene Expression Profiling; Hypertension; Hypertrophy, Left Ventricular; Losartan; Oligonucleotide Array Sequence Analysis; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2009 |
Pleiotropic effects of the acute and chronic inhibition of the renin-angiotensin system in hypertensives.
Topics: Acute Disease; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Chronic Disease; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Losartan; Male; Middle Aged; Quinapril; Reference Values; Renin-Angiotensin System; Severity of Illness Index; Stroke Volume; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Ventricular Pressure | 2014 |